Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

NCT06564974 · clinicaltrials.gov ↗
RECRUITING
Status
250
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Catalyst Pharmaceuticals, Inc.

Collaborators